A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

NCT02919319 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: ACT-541468 (Formulation A)
DRUG: ACT-541468 (Formulation B)
DRUG: Placebo (Formulation A)
DRUG: Placebo (Formulation B)
DRUG: 14C-labeled ACT-541468
DRUG: Placebo tracer

Sponsor

Idorsia Pharmaceuticals Ltd.